ppat.1010928.s009.tif (603.2 kB)
Analysis of LOS production in altered phage susceptibility mutants bearing mutations in capsule-control loci or lon.
figure
posted on 2023-06-08, 17:46 authored by Jinna Bai, Nicole Raustad, Jason Denoncourt, Tim van Opijnen, Edward GeisingerLOS production in cell lysates of mutants in bfmRS (A), rnaA and dsbA (B), and lon (C) was analyzed in comparison with WT control via Pro-Q 300 emerald staining. Representative gels are shown in top panels. Arrowhead indicates location of novel intermediate band associated with ∆bfmS (A). Quantification is shown in bottom panels. Bars show mean ± s.d. (n = 3). Within each set of strains, no significant difference (P > 0.05) observed in total LOS levels by one-way ANOVA (A, B) or unpaired t-test (C).
(TIF)
History
Usage metrics
Categories
Keywords
t2 rnase proteinspontaneous resistance mappingresistant nosocomial pathogeninformation could leadimproved antimicrobial therapiesgained renewed interestdiv >< pglobal regulator bfmrsphage remains limiteddetermine phage infectivityidentified novel bfmrsblocking loki infectioncapsule modulation provideslytic phage lokialter capsule structureacinetobacter baumannii loki infectionbaumannii acinetobacter capsule modulationstructural modulationphage challengereducing capsuleloki usesloki replicationloki adsorptionk3 capsulecapsule synthesisphage susceptibilitywork demonstrateswide determinantsusing tnunknown mechanismstranscriptional regulationthreatening infectionsstudies focusedresults supportopposite effectmajor determinantkey centerincluding knockoutsinactivating mutationsidentified genomehypersensitize bacteriahost killingessential receptoradjunctive treatmentactivating mutations